CONGRATULATIONS ON A RECORD-BREAKING WEEK NO. 166 WITH SUPER-DUPER CLOSING OF THE “LOCKDOWN SPECIAL OFFER” #  ATTEND 100TH WELOCITY WEBINAR @ 8 PM ON SUNDAY, 5 JULY 2020 FOR EXCITING ANNONCEMENTS > WELOCITY CORPORATE OFFICE IS FUNCTIONING WITH 10% CAPACITY EFFECTIVE MONDAY, 8 JUNE 2020 # ALL WELLNESS PRODUCTS & DNA KITS ARE BEING DISPATCHED & DELIVERED PROMPTLY, ACROSS INDIA  #  STAY HOME - STAY HEALTHY - LET US BEAT CORONA VIRUS OUT OF THE PARK...!!

 

  • kenburns1
    SKU
    DNA0105
    GET IT
    NOW
    Welocity Genetics Program
    Product Name : Welocity Genetics Program
    SKU Code : DNA0105
    Shipping Charges : Rs. 0
    Stock Status : Available
  • 1) Vitamin A deficiency
  • 2) Vitamin B6 deficiency
  • 3) Vitamin B9 metabolism
  • 4) Vitamin B12 deficiency
  • 5) Vitamin C deficiency
  • 6) Vitamin D deficiency
  • 7) Vitamin E deficiency
  • 8) Vitamin K deficiency
  • 9) Calcium deficiency
  • 10) Gluten intolerance
  • 11) Lactose intolerance
  • 12) Blood pressure and Heart attack response to Caffeine
  • 13) Salt Sensitivity and Hypertension risk
  • 14) Obesity risk
  • 15) Response to dieting
  • 16) Weight regain risk
  • 17) Satiety
  • 18) Adiponectin level
  • 19) Regulation of lipolysis (fat breakdown) and thermogenesis
  • 20) Appetite response to ginger supplementation
  • 21) BMI Response to PUFA
  • 22) BMI Response to MUFA
  • 23) Fatty Acid Metabolism
  • 24) Type 1 diabetes risk
  • 25) Type 2 diabetes risk
  • 26) Impaired glucose metabolism
  • 27) Insulin sensitivity
  • 28) Insulin metabolism
  • 29) Insulin resistance
  • 30) HBA1c response to fibre
  • 31) Insulin resistance to whole grains
  • 32) Congenital hyperinsulinism
  • 33) Hypothyroidism
  • 34) Cholesterol metabolism
  • 35) Lipid (fat) metabolism
  • 36) Cholesterol response to Calorie restriction
  • 37) Hypertriglyceridemia risk
  • 38) Atherosclerosis risk
  • 39) Sudden cardiac arrest risk
  • 40) Vasoconstriction risk
  • 41) Hypertension risk
  • 42) Coronary artery disease risk
  • 43) Dilated and hypertrophic cardiomyopathy risk
  • 44) Homocysteine level regulation
  • 45) Cancer susceptibility
  • 46) Predisposition to Sickle Cell disease
  • 47) Gall stone predisposition
  • 48) Irritable bowel syndrome risk
  • 49) Peptic Ulcer risk
  • 50) Non Alcoholic Fatty Liver Disease Risk
  • 51) Gilbert's syndrome risk
  • 52) Risk of Parkinson's disease
  • 53) Risk of Alzheimer's disease
  • 54) Marfan syndrome
  • 55) Schizophrenia risk
  • 56) Autism risk
  • 57) Risk of Migraine (with aura)
  • 58) Attention Deficit Hyperactivity Disorder (ADHD) risk
  • 59) Risk of Arthritis
  • 60) Allergic Rhinitis risk
  • 61) Risk of Asthma
  • 62) Risk of Inflammation
  • 63) F - Polycystic Ovary Syndrome (PCOS) risk
  • 64) F - Pregnancy loss and Abnormal reproductive function risk in females
  • 65) F - Stress related peripartum depression risk
  • 66) F - Risk of Spot Baldness in females (Alopecia Areata)
  • 63) M - Pituitary-testicular endocrine function risk in males
  • 64) M - Abnormal reproductive function risk in Male
  • 65) M - Prostate Cancer risk
  • 66) M - Risk of Spot Baldness in males (Alopecia Areata)
  • 67) Risk of Hyperuricemia
  • 68) Autosomal Dominant Polycystic Kidney Disease Risk
  • 69) Risk of Diabetic retinopathy
  • 70) Risk of Glaucoma
  • 71) Risk of Cataract
  • 72) Risk of Myopia
  • 73) Risk of Retinitis Pigmentosa
  • 74) Ocular Hypertension
  • 75) DNA Damage risk
  • 76) Early ageing risk
  • 77) Metformin response
  • 78) Response to Pioglitazone treatment in Type 2 Diabetes
  • 79) Response to Sulfonylureas treatment in Type 2 Diabetes
  • 80) Response to Statins
  • 81) Response to Anti-Hypertensive drugs
  • 82) Warfarin response
  • 83) Metabolism of drugs
  • 84) Xenobiotic toxicity risk
  • 85) Dopamine metabolism
  • 86) Depression risk
  • 87) Anxiety Disorder risk
  • 88) Desire for food
  • 89) Eating disorders
  • 90) Alcohol dependency
  • 91) Addiction towards drugs
  • 92) Addiction towards smoking
  • 93) Personality disorder
  • 94) Language learning ability
  • 95) Decision making ability
  • 96) ACTN3 Profile: Power vs Endurance training
  • 97) Muscle damage risk
  • 98) Susceptibility to ankle injury
  • 99) Susceptibility to knee injury
  • 100) Exercise Associated Inflammation risk
  • 101) VO2 max improvement
  • 102) Insulin sensitivity response to exercise
  • 103) Blood Pressure response to exercise
  • 104) Weight loss response to exercise
  • 105) Risk of Osteoporosis